Ortin Laboratories (BOM:539287) Days Sales Outstanding : 328.73 (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Ortin Laboratories Days Sales Outstanding?

Ortin Laboratories's average Accounts Receivable for the three months ended in Dec. 2023 was ₹4.90 Mil. Ortin Laboratories's Revenue for the three months ended in Dec. 2023 was ₹1.36 Mil. Hence, Ortin Laboratories's Days Sales Outstanding for the three months ended in Dec. 2023 was 328.73.

The historical rank and industry rank for Ortin Laboratories's Days Sales Outstanding or its related term are showing as below:

BOM:539287' s Days Sales Outstanding Range Over the Past 10 Years
Min: 66.71 Med: 158 Max: 917.65
Current: 240.33

During the past 13 years, Ortin Laboratories's highest Days Sales Outstanding was 917.65. The lowest was 66.71. And the median was 158.00.

BOM:539287's Days Sales Outstanding is ranked worse than
95.59% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.84 vs BOM:539287: 240.33

Ortin Laboratories's Days Sales Outstanding increased from Dec. 2022 (225.15) to Dec. 2023 (328.73).

Ortin Laboratories Days Sales Outstanding Historical Data

The historical data trend for Ortin Laboratories's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ortin Laboratories Days Sales Outstanding Chart

Ortin Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

66.71

69.33

917.65

158.56

201.69

Ortin Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															225.15	214.10	198.51	172.28	328.73

Competitive Comparison of Ortin Laboratories's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Ortin Laboratories's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ortin Laboratories's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ortin Laboratories's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Ortin Laboratories's Days Sales Outstanding falls into.

Ortin Laboratories Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Ortin Laboratories's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (32.361	+	34.174)	/	2 )	/	60.203	*	365
=	33.2675					/	60.203	*	365
=	201.69

Ortin Laboratories's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (4.903	+	0)	/	1 )	/	1.361	*	365 / 4
=	4.903					/	1.361	*	365 / 4
=	328.73

Ortin Laboratories (BOM:539287) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Ortin Laboratories Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Ortin Laboratories's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Ortin Laboratories (BOM:539287) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ortin Laboratories Ltd (BOM:539287) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

ORTINLAB:India

Address

Street no. 3, D. No. 1-8-B4, Ground Floor,Block-4, F3 HIG, Baghlingampally, Hyderabad, TG, IND, 500 044

Website

https://www.ortinlabsindia.com

Ortin Laboratories Ltd is an India based engaged in the manufacturing and trading of Pharmaceuticals, Drugs, and Intermediates. Its formulations include anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, antibiotics, antifungal, cephalosporins, and others. Some of its APIs Intermediates include Ciprofloxacin, Tramadol, Efavarenz, Lamivudine, Zudavudine, Nevirapine, Lopinavir, Fluconazole, Triclabendazole, Omeprazole, and others.It earns key revenue from domestic sales.

Ortin Laboratories (BOM:539287) Headlines

No Headlines